Blood Volume Monitoring Animation – Crit-Line® Technology
Crit-Line® technology is the latest innovation in blood volume monitoring and provides real-time clinically relevant parameters that help clinicians to optimize fluid removal, maximize ultrafiltration, and reduce the risk of intra-dialytic symptoms in dialysis patients.
The Mechanism of Action (MoA) animation for the technology platform allows the audience to gain an insight into the challenges associated with fluid overload in the end-stage renal disease population and the benefit of Crit-Line® profiles, to gain insight on your patient’s tolerance to the ultrafiltration goal.
The assets for the animation were also used to create an interactive application for mobile and an interactive touchscreen experience.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.
‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.’’
Product Manager, GSK
‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.’’
Oncology Clinical Liaison, Bristol-Myers Squibb
‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics
‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen